Recurrent Adrenocortical Carcinoma
5 clinical trials · Condition
◉ Watch Recurrent Adrenocortical Carcinoma
| Record | Firm | Date |
|---|---|---|
| Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery (NCT00848016) | National Cancer Institute (NCI) | 2009-02-01 |
| Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00831844) | National Cancer Institute (NCI) | 2009-01-01 |
| IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery (NCT00778817) | National Cancer Institute (NCI) | 2008-12-01 |
| Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment (NCT00091182) | National Cancer Institute (NCI) | 2004-10-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
Track Recurrent Adrenocortical Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.